Studies are increasingly showing that GLP-1 medications are most effective (and least disruptive) when users increase physical activity, eat nutrient-dense foods like beans, berries, eggs, and fatty fish, supplement as needed, and pay attention to hydration and sleep
phc hi da ton din, vitamin C thng l la chn tt hn, mc d glutathione vn c th tng cng sc sng cho da
New England Journal of Medicine 384, 9891002 (2021)
GLP-1 receptor agonists may be appropriate for select patients with fatty liver disease, particularly those with concurrent metabolic conditions
[64], tirzepatide effectively reduced VAT inflammation by inhibiting M1-type macrophage infiltration in the visceral fat of obese mice (Table 3)
This systemic inflammation has been linked to an increased risk and severity of conditions, including type 2 diabetes, cardiovascular disease, and obesity